; and (2) the campaign uses targeted, culturally appropriate messages and messengers to reach underserved communities. (c) Authorization of appropriations There are authorized to be appropriated to carry out this section such sums as may be necessary for each of fiscal years 2021 through 2025. XI Research 1101. Research and development The Secretary of Health and Human Services, in coordination with the Director of the Centers for Disease Control and Prevention and in collaboration with the Director of the National Institutes of Health, the Director of the Agency for Healthcare Research and Quality, the Commissioner of Food and Drugs, and the Administrator of the Centers for Medicare & Medicaid Services, shall support research and development on more efficient and effective strategies— (1) for the surveillance of SARS–CoV–2 and COVID–19; (2) for the testing and identification of individuals infected with COVID–19; and (3) for the tracing of contacts of individuals infected with COVID–19. 1102. CDC field studies pertaining to specific health inequities (a) In general Not later than 90 days after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the Secretary ), acting through the Centers for Disease Control and Prevention, in collaboration with State, local, Tribal, and territorial health departments, shall complete (by the reporting deadline in subsection (b)) field studies to better understand health inequities that are not currently tracked by the Secretary. Such studies shall include an analysis of— (1) the impact of socioeconomic status on health care access and disease outcomes, including COVID–19 outcomes; (2) the impact of disability status on health care access and disease outcomes, including COVID–19 outcomes; (3) the impact of language preference on health care access and disease outcomes, including COVID–19 outcomes; (4) factors contributing to disparities in health outcomes for the COVID–19 pandemic